Tonix signs second managed Medicare agreement for TONMYA, adding 21 million covered lives

• Tonix Pharmaceuticals signed a second major managed Medicare payer agreement covering TONMYA for adult fibromyalgia, effective immediately.
• Deal adds about 21 million Medicare lives, lifting Medicare coverage to 32 million lives, or 58% of the US Medicare market.
• Total commercial and government coverage for TONMYA rises to about 166 million lives, or 53% of total US lives.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tonix Pharmaceuticals Holding Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609220700PRIMZONEFULLFEED9830760) on September 22, 2026, and is solely responsible for the information contained therein.